Tempus AI Gets FDA Green Light for Simpler Tumor-Only Cancer Test

Tempus AI gets FDA approval for tumor-only cancer DNA test, making diagnosis easier and boosting future revenue potential.

Tempus AI Gets FDA Green Light for Simpler Tumor-Only Cancer Test
Credit: Tempus AI
Already have an account? Sign in.